Azopt (Alcon Laboratories, Inc.)


Welcome to the PulseAid listing for the Azopt drug offered from Alcon Laboratories, Inc.. This Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Alcon Laboratories, Inc.
NON-PROPRIETARY NAME: brinzolamide
SUBSTANCE NAME: BRINZOLAMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carbonic Anhydrase Inhibitor [EPC],Carbonic Anhydrase Inhibitors [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: SUSPENSION/ DROPS
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1998-04-30
END MARKETING DATE: 0000-00-00


Azopt HUMAN PRESCRIPTION DRUG Details:

Item DescriptionAzopt from Alcon Laboratories, Inc.
LABELER NAME: Alcon Laboratories, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 10(mg/mL)
START MARKETING DATE: 1998-04-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0065-0275_6a15ac34-058c-447d-384e-142206d08d28
PRODUCT NDC: 0065-0275
APPLICATION NUMBER: NDA020816

Other BRINZOLAMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Alcon Laboratories, Inc.Azopt